| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.3 | 0.2 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |